KA
AVNS

Klingman & Associates’s Avanos Medical AVNS Stock Holding History

Klingman & Associates’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-29
Closed -$1K – 111
2016
Q3 		$1K Hold
29
– – ﹤0.01% 354
2016
Q2 		$1K Hold
29
– – ﹤0.01% 364
2016
Q1 		$1K Hold
29
– – ﹤0.01% 370
2015
Q4 		$1K Hold
29
– – ﹤0.01% 382
2015
Q3 		$0 Hold
29
– – ﹤0.01% 417
2015
Q2 		$1K Sell
29
-33
-53% -$1.48K ﹤0.01% 392
2015
Q1 		$3K Hold
62
– – ﹤0.01% 338
2014
Q4 		$2K Buy
+62
New +$2.44K ﹤0.01% 356

Other funds holding AVNS

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
SCM
Shapiro Capital Management Atlanta, Georgia $1.6B AUM 13.27% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return

Klingman & Associates's AVNS Position: Q4 2016 in Review

Klingman & Associates sold out of Avanos Medical (AVNS) in Q4 2016, closing a stake of 29 shares — an estimated $1K sold.

Klingman & Associates first reported a position in AVNS in Q4 2014 and held it in 8 quarters. The position peaked at $3K in Q1 2015. 360 funds tracked by Wall St. Rank hold AVNS as of Q4 2016.

  • Klingman & Associates reported no remaining Avanos Medical position as of Q4 2016 after selling out during the quarter.
  • Klingman & Associates sold 29 Avanos Medical shares in Q4 2016, an estimated $1K.
  • Klingman & Associates first reported a position in Avanos Medical in Q4 2014 and held it in 8 quarters.
  • Klingman & Associates's Avanos Medical position peaked at $3K in Q1 2015.
  • 360 funds tracked by Wall St. Rank held Avanos Medical as of Q4 2016.

Based on Klingman & Associates's 13F filing for Q4 2016, filed 26 Jan 2017.